tirzepatide acute kidney injury ameliorates cisplatin-induced by restoring NAMPT/NAD + homeostasis and enhancing Pink1–Parkin–mediated mitophagy Should Mounjaro (tirzepatide) be held

Sustain Trial The SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) clinical trials provide an outline of the efficacy and safety profile of semaglutide and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes as discussed in Capehorn M, et al

Notably, the induction of Plin5 suggests improved coupling between lipid droplet lipolysis and mitochondrial oxidation, allowing fatty acids to be efficiently directed to energy metabolism rather than accumulating as toxic intermediates

Neither term appears in the peer-reviewed literature

Chronic Toxicity No-observed-adverse-effect level (NOAEL): 272 mg/kg/day